N,N-dimethyltryptamine--a possible relationship to schizophrenia?
D000818:Animals; D001362:Avoidance Learning / Q000187:drug effects; D001921:Brain / Q000378:metabolism; D002250:Carbon Radioisotopes; D002746:Chlorpromazine / Q000494:pharmacology; D002849:Chromatography, Gas; D003216:Conditioning, Operant / Q000187:drug effects; D004361:Drug Tolerance; D004569:Electroencephalography; D005059:Euphoria / Q000187:drug effects; D006207:Half-Life; D006213:Hallucinogens / Q000378:metabolism*; D006801:Humans; D007211:Indoles / Q000378:metabolism; D008168:Lung / Q000378:metabolism; D008238:Lysergic Acid Diethylamide / Q000494:pharmacology; D013058:Mass Spectrometry; D051379:Mice; D004130:N,N-Dimethyltryptamine / Q000037:antagonists & inhibitors / Q000378:metabolism / Q000494:pharmacology; D051381:Rats; D012559:Schizophrenia / Q000378:metabolism*; D013997:Time Factors; D014363:Tryptamines / Q000378:metabolism*
D002250:Carbon Radioisotopes; D006213:Hallucinogens; D007211:Indoles; D014363:Tryptamines; D008238:Lysergic Acid Diethylamide; D002746:Chlorpromazine; D004130:N,N-Dimethyltryptamine